GlobeNewsWire
05 Aug 2026, 11:45 UTC · 6w ago
Verdict
Headline takes no side. We score AIFF +1.00 across three claims — strongly bullish.
+1.00strongly bullish
More positive than 98% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish
Firefly Neuroscience saw a 291% year-over-year increase in clinical assessments by TMS center customers using its Evoke platform.
More positive than 92% of claims this week
Firefly maintains a proprietary database of over 200,000 EEG/ERP brain scans, which it claims is the world's largest standardized repository of its kind.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 77% of claims this week
The Evoke system is FDA 510(k)-cleared for diagnostic and treatment monitoring of conditions including depression, dementia, anxiety, and PTSD.
More positive than 65% of claims this week
Which stocks this story touches
More positive than 98% of ticker scores this week
The company reported a nearly four-fold year-over-year increase in clinical assessments using its AI-powered platform.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
1d ago
+5.9%
Price agrees with the score
$1.26 vs $1.19 close before publication (Aug 4) · not market-adjusted
AIFF chart →
